Thymic regeneration could delay the entire cancer aging curve—not by preventing mutations, but by maintaining immune surveillance

Cancer incidence explodes after 60. We blame DNA damage accumulation, but mutation rates don't accelerate that dramatically with age.

The exponential rise tracks thymic involution almost perfectly. As the thymus shrinks, T-cell diversity collapses, and immune surveillance fails.

If thymic regeneration works—restoring a diverse T-cell repertoire—it wouldn't just treat cancer. It would shift the entire age-dependent incidence curve.